Showing results (1021-1030 of 1,099) with videos related to

Sort By:
Pageof 110
Aging|February 24, 2017
Genetic polymorphisms (rs10636 and rs28366003) in metallothionein 2A increase breast cancer risk in Chinese Han populationDi Liu, Meng Wang, Tian Tian, et al.
Journal of Medical Internet Research|September 24, 2015
Online Prediction of Health Care Utilization in the Next Six Months Based on Electronic Health Record Information: A Cohort and Validation StudyZhongkai Hu, Shiying Hao, Bo Jin, et al.
Innovation (Cambridge (Mass.))|October 20, 2025
Divergent accumulation patterns of SNVs and INDELs reveal negative selection in noncancerous cellsLei Zhang, Moonsook Lee, Xiaoxiao Hao, et al.
Plant Physiology|September 22, 2007
yucca6, a dominant mutation in Arabidopsis, affects auxin accumulation and auxin-related phenotypesJeong Im Kim, Altanbadralt Sharkhuu, Jing Bo Jin, et al.
Biology of Reproduction|August 23, 2013
Rapid movement of water and cryoprotectants in pig expanded blastocysts via channel processes: its relevance to their higher tolerance to cryopreservationBo Jin, Ryu-ichi Higashiyama, Yu-ichi Nakata, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Long Noncoding RNA Associations Define an Interferon-Myeloid Immune Axis in Kawasaki DiseaseFang Liu, Xing Xue, Zhi Han, et al.
Plos One|February 10, 2016
Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile IllnessesZhen Li, Zhou Tan, Shiying Hao, et al.
Neurobiology of Disease|January 13, 2024
Widespread slow oscillations support interictal epileptiform discharge networks in focal epilepsyHongyi Ye, Lingqi Ye, Lingli Hu, et al.
Lancet (London, England)|December 11, 2007
Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studiesRajesh Krishna, Matt S Anderson, Arthur J Bergman, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2009
Effect of rifampin, a potent inducer of drug-metabolizing enzymes, on the pharmacokinetics of raltegravirLarissa A Wenning, William D Hanley, Diana M Brainard, et al.
Pageof 110